Twist Bioscience Corp Ratios

Ratios Sep2016 Sep2017 Sep2018 Sep2019 Sep2020 Sep2021 Sep2022 Sep2023 Sep2024 Sep2025
Profitability
Gross Margin -315.20%-123.09%-26.59%12.80%31.85%39.08%41.38%36.61%42.61%50.72%
EBT Margin 1,943.06%-548.25%-279.21%-198.30%-154.88%-116.39%-112.14%-83.01%-66.51%-20.43%
EBIT Margin -2,339.22%-543.16%-277.50%-200.15%-155.47%-115.41%-115.33%-88.60%-70.56%-36.18%
EBITDA Margin 1,942.66%-550.63%-279.95%-197.80%-155.41%-114.59%-108.20%-83.04%-66.62%-20.65%
Operating Margin -2,339.22%-543.16%-277.50%-200.15%-155.47%-115.41%-115.33%-88.60%-70.56%-36.18%
Net Margin 1,943.06%-550.85%-280.16%-198.85%-155.33%-114.94%-107.02%-83.50%-66.70%-20.63%
FCF Margin -537.71%-274.72%-188.83%-168.84%-105.27%-111.14%-69.46%-22.10%-20.08%
Efficiency
Inventory Average 6.68M9.81M22.04M35.55M35.69M28.07M26.19M
Assets Average 151.39M292.94M550.49M831.74M868.89M695.36M628.09M
Equity Average -167.39M-24.67M244.17M458.54M685.10M706.41M548.06M472.82M
Invested Capital -133.36M-198.92M159.58M340.43M582.37M789.38M623.43M472.69M472.96M
Asset Utilization Ratio 0.360.310.240.240.280.450.60
Leverage & Solvency
Interest Coverage Ratio -64.62-53.74-84.12-177.99-416.15-0.00M-0.04M-0.01M
Debt to Equity -0.050.050.010.000.03
Debt Ratio 0.080.040.010.000.02
Equity Ratio -1.740.810.840.830.820.800.770.74
Times Interest Earned -64.62-53.74-84.12-177.99-416.15-0.00M-0.04M-0.01M
Valuation
Enterprise Value -28.60M-31.23M-80.76M639.40M3,103.04M4,794.91M1,481.28M826.43M2,370.51M1,466.11M
Market Capitalization 777.51M3,393.05M5,272.77M1,986.25M1,162.85M2,646.91M1,698.56M
Return Ratios
Return on Sales 19.43%-5.51%-2.80%-1.99%-1.55%-1.15%-1.07%-0.83%-0.67%-0.21%
Return on Capital Employed -0.90%-0.55%-0.31%-0.32%-0.27%-0.35%-0.25%
Return on Invested Capital -0.33%-0.33%
Return on Assets -0.71%-0.48%-0.28%-0.26%-0.24%-0.30%-0.12%
Return on Equity 0.43%4.38%-0.57%-0.33%-0.32%-0.29%-0.38%-0.16%